Lithium Treatment Increases Intact and Midregion Parathyroid Hormone and Parathyroid Volume*
- 1 March 1989
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 68 (3) , 654-660
- https://doi.org/10.1210/jcem-68-3-654
Abstract
Lithium carbonate is known to alter calcium metabolism by lowering urinary calcium excretion and increasing serum calcium concentrations. Several investigators have reported increases in serum immunoreactive PTH (iPTH) values after a few weeks or months of lithium treatment, and several cases of primary hyperparathyroidism developing during lithium treatment have been reported. To determine whether the increases in serum iPTH might be the result of increased renal retention of inactive PTH fragments rather than stimulation of parathyroid function, we measured plasma intact PTH by im-munoradiometric assay and estimated parathyroid size by ultra-sonography in men who had received short term (3 yr) lithium treatment and in normal subjects. Serum ionized calcium was higher by 0.03–0.04 mmol/L in subjects treated short term (mean, 1.7 months) with lithium than in normal subjects, but plasma intact PTH and serum midregion iPTH values were not different. The absence of a reciprocal decrease in PTH values is compatible with a lithium-induced shift in the set-point for the inhibition of PTH secretion by calcium toward a higher calcium value. Both plasma intact PTH and serum midregion PTH values were higher in subjects during longer term (mean, 103 months) lithium treatment, and estimated parathyroid volume was 3-fold higher. Serum phosphate was lower, and serum chloride and plasma 1,25-dihydroxy-vitamin D values were higher in those treated with lithium long term, probably from the biological action of the increased PTH. We conclude that long term lithium treatment increases circulating biologically active PTH and causes parathyroid enlargement. Whether this chronic stimulus to parathyroid growth might lead to adenoma formation in certain susceptible individuals and whether a PTH-induced increase in skeletal remodelling occurs that might hasten the appearance of osteopenia remain to be determined.Keywords
This publication has 10 references indexed in Scilit:
- Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure.Clinical Chemistry, 1986
- High-resolution parathyroid sonographyAmerican Journal of Roentgenology, 1982
- Radioimmunoassay for the Middle Region of Human Parathyroid Hormone Using an Homologous Antiserum with a Carboxy-Terminal Fragment of Bovine Parathyroid Hormone as Radioligand*Journal of Clinical Endocrinology & Metabolism, 1982
- High-resolution real-time sonography of the parathyroid.Radiology, 1981
- LITHIUM INDUCES ABNORMAL CALCIUM-REGULATED PTH RELEASE IN DISPERSED BOVINE PARATHYROID CELLS1Journal of Clinical Endocrinology & Metabolism, 1981
- Lithium's effect of parathyroid hormoneAmerican Journal of Psychiatry, 1981
- Development of ‘Primary’ Hyperparathyroidism during Lithium Therapy: Longitudinal StudyNeuropsychobiology, 1980
- ENDOCRINE EFFECTS OF LITHIUM:Acta Endocrinologica, 1978
- Lithium inhibition of bone mineralization and osteoid formation.Journal of Clinical Investigation, 1978
- Parathyroid UltrasonographyRadiology, 1978